A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3)
Clinical trial NCT04855721 · COMPLETED
Trial details
- NCT number
- NCT04855721
- Sponsor
- Aurigene Discovery Technologies Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-04
- Primary completion
- 2022-11-30
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.